###begin article-title 0
###xml 1 2 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice
###end article-title 0
###begin p 1
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Transmitting editor:</italic>
Transmitting editor: A. Falus
###end p 1
###begin p 2
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press and The Japanese Society for Immunology are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 2
###begin p 3
###xml 1298 1299 1294 1295 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 1302 1303 1298 1299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 57 63 <span type="species:ncbi:10090">murine</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 270 275 <span type="species:ncbi:10090">mouse</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 1024 1028 <span type="species:ncbi:10090">mice</span>
###xml 1492 1496 <span type="species:ncbi:10090">mice</span>
Proteoglycan (PG) aggrecan-induced arthritis (PGIA) is a murine model of rheumatoid arthritis (RA). Although BALB/c and DBA/2 mice share the same MHC (H-2d) haplotype, the BALB/c strain is susceptible to PGIA, while DBA/2 mice are resistant. Therefore, these two inbred mouse strains provide an opportunity to study arthritis susceptibility factors excluding the effects of MHC-associated genetic components. The goal of this study was to monitor changes in the cellular composition and activation state following intra-peritoneal (i.p.) immunization to induce PGIA; additionally, we sought to identify new susceptibility factors by comparing PG-induced immune responses in BALB/c and DBA/2 mice. Upon i.p. PG injection, resident naive B1 cells are replaced by both T cells and conventional B cells in the peritoneum of BALB/c mice. These peritoneal T cells produce IFNgamma and IL-17, cytokines shown to be important in RA and corresponding arthritis models. Moreover, peritoneal cells can adoptively transfer PGIA to SCID mice, demonstrating their arthritogenic properties. Our results indicate that repeatedly injected antigen leads to the recruitment and activation of immune cells in the peritoneum; these cells then trigger the effector phase of the disease. The migration and activation of Th1/Th17 cells in the peritoneal cavity in response to PG immunization, which did not occur in the arthritis-resistant DBA/2 strain, may be critical factors of arthritis susceptibility in BALB/c mice.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 501 502 501 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 849 850 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 1078 1079 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 66 72 <span type="species:ncbi:10090">murine</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 872 877 <span type="species:ncbi:9606">human</span>
###xml 984 990 <span type="species:ncbi:10090">murine</span>
###xml 1054 1059 <span type="species:ncbi:9606">human</span>
###xml 1064 1070 <span type="species:ncbi:10090">murine</span>
Proteoglycan (PG) aggrecan-induced arthritis (PGIA) is one of the murine models of rheumatoid arthritis (RA). Repeated intra-peritoneal (i.p.) immunization with human cartilage PG (aggrecan) leads to joint inflammation, progressive cartilage destruction, bone erosion and ankylosis in diarthrodial joints of genetically susceptible BALB/c mice (1). Autoimmune features of PGIA, such as autoreactivity, T and B cell involvement and the cytokine profile in serum and synovial fluid closely resemble RA (2). Additional features common to RA are that this model includes early involvement of small synovial joints, similar X-ray and histopathologic abnormalities of peripheral joints, greater susceptibility of aging females, dominant, but not exclusive, effect of MHC, the polygenic character and the recessive inheritance of the disease [reviewed in (2)]. Immunization with human cartilage PG aggrecan leads to the breakdown of self-tolerance, and it triggers an autoimmune response to murine cartilage PG due to the presence of cross-reactive epitopes in human and murine PGs (3-5).
###end p 5
###begin p 6
The i.p. route of immunization appears to be critical for disease induction in the PGIA model. Although intra-dermal, subcutaneous or intra-muscular administration of the same PG antigen induces massive T and B cell responses, the severity of arthritis is weaker. Therefore, it is a logical approach to study immunological events in the peritoneum that may determine the development and progression of this autoimmune disease.
###end p 6
###begin p 7
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 791 793 791 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 241 246 <span type="species:ncbi:9606">human</span>
The peritoneal cavity is a unique microenvironment, lined by a serous membrane that consists of a mesothelial layer and sub-mesothelial connective tissue, containing blood and lymphatic vessels, and lymphoid tissue (6). 'Milky spots' on the human omentum, containing mostly macrophages and lymphocytes, may be considered secondary lymphoid foci within the peritoneal cavity (7). The peritoneal fluid contains different types of immune cells, such as macrophages, lymphocytes and dendritic cells (6). B1 lymphocytes represent a major cell population in the peritoneum; however, this cell type is rare in other tissues (8). A major function of these B1 cells is thought to be the production of IgM (9), although effective antigen presentation is another significant feature of these B1 cells (10, 11). Furthermore, two functionally different B1 cell sub-populations (B1a/b) can be defined based on the expression of the CD5 molecule, a cell surface receptor that is otherwise expressed by T cells (12).
###end p 7
###begin p 8
###xml 211 212 211 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 265 266 265 266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 139 142 <span type="species:ncbi:31658">CFA</span>
Besides the site of immunization (antigen entry), the direction of the immune response is largely determined by the adjuvant. For example, CFA and dimethyldioctadecyl-ammonium bromide (DDA) are known to induce Th1 type immune responses, while alum adjuvant favors Th2 polarization (13-15). Adjuvants exert these effects mainly by activating the cells of innate immunity (14, 16). DDA enhances both cellular and humoral immune responses when injected i.p. but primarily supports cellular immunity when administered subcutaneously (17).
###end p 8
###begin p 9
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 784 785 784 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 810 811 810 811 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
PGIA can be induced in genetically susceptible BALB/c mice, however, most other strains are resistant, for example the MHC-matched DBA/2 is a resistant strain (1, 18, 19). Although the difference in arthritis susceptibility between these two strains has been known for >20 years (18) and the fundamental cellular and immunological mechanisms leading to the development of PGIA have been described [see for review, ref. (2)], the most critical susceptibility factors have not been elucidated. PGIA is a T cell-dependent, B cell- and/or antibody-mediated disease (2, 18). The disease cannot be adoptively transferred by T cells, B cells or antibodies alone to naive BALB/c or SCID mice; successful transfer requires both T cells and either B cells or antibodies from arthritic animals (5, 20). A shift toward a Th1-dominant cytokine profile is necessary for disease development (21, 22), and IL-4 has been shown to act as a negative regulator, or a protective cytokine, in PGIA (23).
###end p 9
###begin p 10
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
The induction phase of this autoimmune disease begins with the activation of PG-specific T and B cells, eventually overcoming self-tolerance; this takes place during the immunization regime (18). Therefore, we chose to characterize the early events following i.p. immunization, when joint inflammation was not yet present. We then extended our study by analyzing changes in cellular composition, activation markers, cytokine production, T cell response and antibody production during the entire immunization period.
###end p 10
###begin p 11
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 936 940 <span type="species:ncbi:10090">mice</span>
Here we report that the earliest events in the peritoneum following i.p. PG immunization are the disappearance of resident naive B1 cells and their replacement by T cells and conventional B cells in BALB/c mice. This re-organization of the cellular composition following repeated injections of antigen suggests that the generation of activated effector cells, beginning in the peritoneum, triggers the effector phase of the disease. Moreover, the arthritogenic potential of these activated peritoneal cells is confirmed by their ability to adoptively transfer PGIA to SCID mice. Adjuvant DDA plays a crucial role in initiating the change of cellular composition in the peritoneal cavity, but DDA itself is not capable of disease induction. Changes in the cellular composition in response to PG injection, which do not occur in the MHC-matched arthritis-resistant DBA/2 strain, appear to determine the arthritis susceptibility of BALB/c mice to PGIA.
###end p 11
###begin title 12
Materials and methods
###end title 12
###begin title 13
Chemicals
###end title 13
###begin p 14
###xml 459 460 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 143 148 <span type="species:ncbi:10090">Mouse</span>
All chemicals, unless indicated otherwise, were purchased from Sigma Chemical Co. (St Louis, MO, USA) or Fisher Scientific (Chicago, IL, USA). Mouse recombinant cytokines and ELISA kits were purchased from R&D Systems (Minneapolis, MN, USA) or BD Biosciences (San Jose, CA, USA). PBS (pH 7.4) was used for washing and short-term storage of cells until use. Cell surface labeling with mAbs was carried out in flow cytometry wash buffer (PBS containing 0.1% NaN3 and 0.1% BSA). Intracellular FoxP3 labeling was performed in permeabilization buffer after fixation of surface-stained cells (eBioscience, San Diego, CA, USA).
###end p 14
###begin title 15
Antigen, animals and immunization
###end title 15
###begin p 16
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
Articular cartilage was collected from patients undergoing knee joint replacement surgery. The collection of cartilage from consenting patients was approved by the Institutional Review Board of Rush University Medical Center. Cartilage PG (aggrecan) was extracted and depleted of glycosaminoglycan side chains as described (24).
###end p 16
###begin p 17
###xml 272 280 272 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cid/scid</italic>
###xml 504 506 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 703 705 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 725 726 724 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">Mice</span>
###xml 670 674 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 969 973 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
All animal procedures were conducted under a protocol approved by the Institutional Animal Care and Use Committee of Rush University Medical Center. Female BALB/c and DBA/2 mice of 16-20 weeks of age and sex- and age-matched SCID mice of BALB/c background (NCI/NCrC.B-17-scid/scid; henceforth SCID) were purchased from the National Cancer Institute (Fredrick, MD, USA). Mice were immunized via i.p. injection with an emulsion of cartilage PG (100 mug protein) and 2 mg DDA adjuvant on days 0, 21 and 42 (24). Groups of animals were sacrificed 5, 10 and 20 days after the first, second and third immunizations, respectively. Adoptive transfer of PGIA from BALB/c to SCID mice was performed as described (20). Briefly, 1-3 x 106 peritoneal lavage fluid (PLF) cells, harvested 10 days after the first, second and third immunization, were injected i.p. with 100 mug PG into SCID mice, twice 10-14 days apart. In preliminary experiments, PLF cells of PG/DDA-immunized DBA/2 mice (after four immunizations) were also used for adoptive transfer, and cell compositions of the PLF were determined in CD44- and CD62L-deficient BALB/c mice after PG/DDA injections.
###end p 17
###begin title 18
Clinical assessment of arthritis
###end title 18
###begin p 19
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
PG-immunized BALB/c, DBA/2 and recipient SCID mice were examined three to four times a week for clinical symptoms of arthritis. The time of onset and incidence of arthritis were recorded, and severity was scored visually based upon the swelling and redness of each paw, ranging from zero to four, yielding a maximum severity score of 16 per mouse (1, 18, 24).
###end p 19
###begin title 20
mAbs
###end title 20
###begin p 21
###xml 108 124 <span type="species:ncbi:10032">Armenian hamster</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 171 174 <span type="species:ncbi:10116">rat</span>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
###xml 229 232 <span type="species:ncbi:10116">rat</span>
###xml 238 243 <span type="species:ncbi:10090">mouse</span>
###xml 281 284 <span type="species:ncbi:10116">rat</span>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 351 354 <span type="species:ncbi:10116">rat</span>
###xml 360 365 <span type="species:ncbi:10090">mouse</span>
###xml 404 420 <span type="species:ncbi:10032">Armenian hamster</span>
###xml 426 431 <span type="species:ncbi:10090">mouse</span>
###xml 470 473 <span type="species:ncbi:10116">rat</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
###xml 522 525 <span type="species:ncbi:10116">rat</span>
###xml 531 536 <span type="species:ncbi:10090">mouse</span>
###xml 577 580 <span type="species:ncbi:10116">rat</span>
###xml 586 591 <span type="species:ncbi:10090">mouse</span>
###xml 631 634 <span type="species:ncbi:10116">rat</span>
###xml 640 645 <span type="species:ncbi:10090">mouse</span>
###xml 679 682 <span type="species:ncbi:10116">rat</span>
###xml 688 693 <span type="species:ncbi:10090">mouse</span>
###xml 732 735 <span type="species:ncbi:10116">rat</span>
###xml 741 746 <span type="species:ncbi:10090">mouse</span>
###xml 793 796 <span type="species:ncbi:10116">rat</span>
###xml 802 807 <span type="species:ncbi:10090">mouse</span>
###xml 843 846 <span type="species:ncbi:10116">rat</span>
###xml 852 857 <span type="species:ncbi:10090">mouse</span>
###xml 894 897 <span type="species:ncbi:10116">rat</span>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
The following fluorochrome-labeled or biotinylated mAbs were purchased from BD Biosciences: FITC-conjugated Armenian hamster anti-mouse CD69 (clone H1.2F3), PE-conjugated rat anti-mouse CD8 (clone 53-6.7), PerCP-Cy5.5-conjugated rat anti-mouse CD4 (clone RM4-5), PE-Cy7-conjugated rat anti-mouse B220 (clone RA3-6B2), Allophycocyanin (APC)-conjugated rat anti-mouse CD25 (clone PC61), APC-Cy7-conjugated Armenian hamster anti-mouse CD3 (clone 145-2C11), FITC-conjugated rat anti-mouse IgD (clone 11-26c.2a), PE-conjugated rat anti-mouse CD43 (clone S7), PerCP-Cy5.5-conjugated rat anti-mouse IgM (clone R6-60.2), PE-Cy7-conjugated rat anti-mouse CD19 (clone 1D3), APC-conjugated rat anti-mouse CD5 (clone 53-7.3), biotin-conjugated rat anti-mouse CD23 (clone B3B4), Alexa Fluor 488-conjugated rat anti-mouse CD44 (clone IM7) and PE-conjugated rat anti-mouse CD62L (clone MEL-14). PE-conjugated rat anti-mouse FoxP3 (clone FJK-16s) was purchased from eBioscience. Biotinylated mAbs were detected by the use of APC-Cy7-conjugated streptavidin.
###end p 21
###begin title 22
Fluorescent cell surface labeling
###end title 22
###begin p 23
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 855 858 <span type="species:ncbi:10116">rat</span>
We used a three- to six-color labeling technique for the simultaneous detection of cell surface and intracellular molecules in cells harvested from the PLF and spleen of mice. Briefly, 1 x 106 cells were seeded in 96-well U-bottom assay plates (BD Falcon). Fc receptors were blocked with anti-CD16/32 (FcBlock, BD Biosciences) at 4degreesC for 15 min, and cells were then incubated with mAb cocktails in 100 mul flow cytometry staining buffer at 4degreesC in the dark for 30 min. Cells were washed twice and finally re-suspended in 200 mul of 0.1% formaldehyde in PBS. If biotinylated mAb was used, fluorochrome-labeled streptavidin was added to the samples after washing, and cells were then incubated at 4degreesC in the dark for another 30 min. Intracellular FoxP3 was stained after fixation and permeabilization of cells. Isotype-matched control IgG (rat or hamster) for each color was used for background staining.
###end p 23
###begin title 24
Flow cytometric measurement and phenotypic analysis, definition of cell populations
###end title 24
###begin p 25
###xml 405 408 405 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 412 416 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 461 465 461 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 469 472 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
Samples were measured and analyzed using a FACS Canto II flow cytometer and FACS DIVA software (BD Biosciences). Acquisition was performed by gating on lymphoid cells within forward/side-scatter dot plots. Cell surface marker-defined populations were as follows-CD3+: total T cells; CD3+ CD4+: CD4+ T cells; CD3+ CD8+: CD8+ T cells; CD4+ CD25+ FoxP3+: regulatory T cells (Tregs); B220+: total B cells; IgDlow IgMhigh CD19+ CD23- CD5+/-: B1 cells (B1a/b) and IgDhigh IgMlow CD19+ CD23+: conventional B2 cells (25). Specific cell proportions were expressed as percentage of total cells unless otherwise stated. Data were collected from 10 000 cells within the lymphoid gate in each sample. We used fluorescent histogram plots to compare mean fluorescence intensities of different samples and to calculate the proportions of positively stained cells.
###end p 25
###begin title 26
Measurement of PG-specific antibodies and T cell response
###end title 26
###begin p 27
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 425 431 <span type="species:ncbi:9986">rabbit</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
Serum samples, PLF and spleen cells were harvested from BALB/c and DBA/2 mice before and at different time points after each immunization and also from adoptively transferred SCID mice 40-50 days after the second cell transfer. PG-specific antibodies were measured using ELISA as described (20, 24). In brief, sera were diluted at the range of 1:100-1:102400, and PG-bound antibodies were detected with peroxidase-conjugated rabbit anti-mouse IgG1 or IgG2a (Zymed Laboratories, San Francisco, CA, USA).
###end p 27
###begin p 28
###xml 96 97 96 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 263 264 261 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 311 313 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 315 317 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 398 400 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 434 436 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 478 480 476 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 515 517 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 585 587 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 628 630 614 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 698 699 684 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 892 893 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 901 903 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 189 194 <span type="species:ncbi:9606">human</span>
Antigen-specific T cell responses were measured in quadruplicate samples of spleen cells (3 x 105 cells per well in 200 mul on 96-well plates) cultured in the absence or presence of 50 mug human PG protein per milliliter. T cell proliferation was assessed using [3H]thymidine incorporation on day 5 of culture (20, 26). Spontaneous and antigen-specific production of IL-4 (detection level: 10 pg ml-1), IL-6 (detection level: 20 pg ml-1), IL-12/23 p40 (detection level: 30 pg ml-1), IL-17 (detection level: 20 pg ml-1), tumor necrosis factor alpha (TNFalpha) (detection level: 50 pg ml-1) and IFNgamma (detection level: 80 pg ml-1) was measured in PLF and spleen cell culture supernatants (1.8 x 106 cells per well in 600 mul on 48-well plates) harvested on day 5 using capture ELISAs (from BD Biosciences or R&D Systems), and the results were expressed as cytokine (picograms) secreted by 106 cells (26).
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
###xml 225 226 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 320 321 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Descriptive statistics were used to determine group means and standard error of the mean (SEM) (mean +/- SEM) unless otherwise stated. The difference between two groups was tested for statistical significance using Student's t-test, and the difference among three or more groups was tested using analysis of variance. A P </=0.05 value was considered to be statistically significant.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Immunophenotypic characterization of naive BALB/c and DBA/2 mice
###end title 32
###begin p 33
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
Since basal immunologic traits of mice may affect the immune response to antigen, in this case PG, which causes arthritis, we first assessed the cellular composition of the PLF, the first site of antigen entry after i.p. injection, and the spleen, which is involved later in the systemic response, in naive BALB/c mice, focusing on lymphoid cell types.
###end p 33
###begin p 34
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 204 208 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 213 217 213 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 331 338 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 571 578 571 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 632 639 632 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
Table 1 compares the distribution and phenotypic properties of T and B cells in these two compartments in naive BALB/c mice. The CD4+/CD8+ T cell ratio was higher in the PLF than the spleen, but the CD62Lhigh/CD44high CD4+ ratio, which denotes resting and activated CD4+ T cells, respectively, was similar in the two compartments (Table 1). A more detailed cell surface marker analysis of the B cell pool in naive BALB/c mice showed that in the PLF, a majority of B cells belonged to the B1 cell sub-population, while the spleen contained more conventional B (B2) cells (Table 1). In the PLF, the CD5+/CD5- B1 cell ratio was 0.145 (Table 1), indicating the dominance of CD5- B1 cells in the naive peritoneal milieu.
###end p 34
###begin p 35
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Immunophenotypic composition of lymphoid cells in PLF and spleen of naive BALB/c mice
###end p 35
###begin p 36
###xml 151 152 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 229 230 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 291 298 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
In spleen, this population is comprised of transitional B cells, marginal zone B cells and B1 cells. Numbers represent mean +/- SD of cell numbers (x106) of five independent measurements. Bold-faced numbers indicate significant (P < 0.05) differences when values from BALB/c and DBA/2 mice (Table 2) are compared (*BALB/c value > DBA/2 value).
###end p 36
###begin p 37
###xml 179 187 179 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
###xml 264 272 264 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
###xml 317 321 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 340 344 340 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 429 437 429 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 442 443 442 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
###xml 583 591 583 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 557 561 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
In MHC-matched, but PGIA-resistant, naive DBA/2 mice, we found significantly fewer T cells but similar numbers of B cells as in naive BALB/c mice, both in the PLF and the spleen (Tables 1 and 2). The CD4+:CD8+ T cell ratio was higher in DBA/2 than in BALB/c mice (Tables 1 and 2). There were significantly fewer CD62Lhigh CD4+ T cells, CD44high CD4+ T cells and Tregs in the spleen of naive DBA/2 mice when compared with BALB/c (Tables 1 and 2). In the PLF, the B1:B2 (conventional) cell ratio was higher, but the CD5+/CD5- B1 cell ratio was lower in DBA/2 mice than in BALB/c mice (Tables 1 and 2).
###end p 37
###begin p 38
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Immunophenotypic composition of PLF and spleen of naive DBA/2 mice
###end p 38
###begin p 39
###xml 151 152 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 518 525 516 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
In spleen, this population is comprised of transitional B cells, marginal zone B cells and B1 cells. Numbers represent mean +/- SD of cell numbers (x106) of five independent measurements. Statistical differences of different cell populations and/or ratios in different lymphoid compartments are not indicated because the presence of these cells represents the normal (naive) cell distribution in the PLF and spleen of naive (non-immunized) DBA/2 mice. Significant differences between BALB/c and DBA/2 are indicated in Table 1.
###end p 39
###begin title 40
Changes in cellular composition of the PLF upon i.p. immunization with PG
###end title 40
###begin p 41
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 95 98 <span type="species:ncbi:31658">CFA</span>
###xml 143 146 <span type="species:ncbi:31658">CFA</span>
###xml 218 221 <span type="species:ncbi:31658">CFA</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
The most efficient way of immunization leading to PGIA is the i.p. injection of PG with either CFA (1) or DDA (14). The use of DDA, instead of CFA, however, became a routine process lately to avoid the side effects of CFA including the complicating effects of heat shock proteins, bacterial cell wall components etc. present in mycobacteria preparations (14). The peritoneal cavity is the entry site of the antigen, where the cells of the immune system first encounter PG and adjuvant. Therefore, we monitored the changes in cellular composition of the PLF at different time points during immunization with PG and DDA, as well as when DDA adjuvant was injected without antigen in both BALB/c and DBA/2 mice.
###end p 41
###begin p 42
###xml 132 145 132 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1A and G</xref>
###xml 387 391 383 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 661 674 657 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1A and G</xref>
###xml 954 961 950 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1A</xref>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
The number of T cells in BALB/c PLF increased significantly compared with naive animals by 10-20 days after the first PG injection (Fig. 1A and G). Most of these T cells were CD4+, and 26.4 +/- 5.4% of the CD4+ cells expressed high levels of CD25 already at day 5 after the first i.p. injection of PG in DDA (data not shown). There was a 2-fold increase (up to 79.3 +/- 2.4%) in the CD44high CD4+ cell percentage, compared with that measured in naive animals (data not shown). After a transient decrease, detected between the second and third i.p. PG/DDA injections, the number of T cells increased again after the third immunization in the PLF of BALB/c mice (Fig. 1A and G). In the PLF of DBA/2 mice, the T cell number remained lower than in BALB/c through the whole immunization period. However, there were transient but significant increases in the T cell number after the second and third i.p. PG + DDA injections compared with the naive DBA/2 PLF (Fig. 1A).
###end p 42
###begin p 43
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 470 471 470 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 496 497 491 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 646 647 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
Cellular composition changes in the peritoneum of BALB/c (black circles) and DBA/2 (open circles) mice in response to PG immunization (A, B and C) or repeated DDA adjuvant injections (D, E and F) as assessed by flow cytometry. Time-dependent changes in the number of T (A and D), B1 (B and E) and conventional B (C and F) cells in the PLF of BALB/c and DBA/2 mice. Values significantly higher (*P < 0.05) in BALB/c than DBA/2, or values that were significantly higher (#P < 0.05) or lower (daggerP < 0.05; in both strains) than in naive animals, are indicated. Data present mean +/- SEM of three to five animals at each time point. Arrows on the x-axis (days 0, 21 and 42) indicate the injections. (G) Flow cytometric contour plots show T cells (green), B1 cells (magenta) and conventional B cells (blue) based on their IgM, IgD, CD19 and CD5 staining in BALB/c mice.
###end p 43
###begin p 44
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 160 164 160 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 345 358 345 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1B and G</xref>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 409 412 409 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 535 548 535 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1C and G</xref>
###xml 724 737 724 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1B and C</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
In contrast to the significant expansion of T cells in the peritoneal cavity of BALB/c mice in response to i.p. immunization, the number of B1 cells (IgDlow IgMhigh CD19+ CD23-) measured in the PLF of naive mice declined from >106 cells to <105 cells within 5 days and remained at a significantly lower level throughout the immunization period (Fig. 1B and G). The number of conventional B cells (IgDhigh, IgMlow, CD19+ and CD23+) dropped after each i.p. injection but always returned close to the levels measured before immunization (Fig. 1C and G). Changes in the B1 cell and conventional B cell numbers showed similar kinetics after i.p. PG injections during the entire immunization period in both BALB/c and DBA/2 mice (Fig. 1B and C).
###end p 44
###begin p 45
###xml 491 500 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1D&#8211;F</xref>
###xml 865 878 865 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1D and F</xref>
###xml 991 998 991 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1E</xref>
###xml 1095 1108 1095 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1D and F</xref>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1089 1093 <span type="species:ncbi:10090">mice</span>
To further dissect whether the changes in cellular composition described above could be attributed to the antigen (PG) or the adjuvant (DDA), we repeated the same immunization protocol with PBS/DDA and monitored the same parameters. We found that DDA alone caused very similar changes in cellular composition (increased T cell and conventional B cell numbers and decreased B1 cell numbers) in the peritoneal cavity of BALB/c mice to what was observed when the antigen (PG) was also present (Fig. 1D-F). However, the kinetics of the T cell number changes were different when we injected mice with DDA alone: the T cell number did not increase after the first DDA injection. On the contrary, especially after the second injection of adjuvant alone, T cell and conventional B cell number changes were more pronounced than after the second injection of PG in adjuvant (Fig. 1D and F). Importantly, in the peritoneal cavity of DBA/2 mice, the DDA injections affected only the B1 cell population (Fig. 1E) and did not cause the T cell or conventional B cell number to increase as seen in BALB/c mice (Fig. 1D and F).
###end p 45
###begin title 46
In vitro cytokine production by BALB/c PLF cells
###end title 46
###begin p 47
###xml 193 200 193 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1A</xref>
###xml 456 463 456 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Because a significant T cell influx was detected in the peritoneum of BALB/c mice as early as day 10 after the first i.p. injection of PG/DDA and since the number of T cells in the peritoneum (Fig. 1A) and their activation profile (as measured by CD25 and CD44) also showed dynamic changes during the immunization period, we measured cytokines that are known to be important regulators of the immune response in PGIA in supernatants of cultured PLF cells (Fig. 2A).
###end p 47
###begin p 48
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 290 292 290 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 350 374 348 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 466 474 464 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 657 658 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 798 799 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 788 793 <span type="species:ncbi:10090">mouse</span>
Kinetics of the immune response to PG in BALB/c mice. Spontaneous (ctrl) and PG-induced (PG) in vitro cytokine production of PLF (A) and spleen (B) cell cultures from BALB/c mice (n = 3 animals at each time point). Numbers show the mean cytokine concentrations of experimental groups (pg 10-6 cells) (mean +/- SEM values are listed in , available at International Immunology Online). Grayscale intensity coding of cytokine concentrations is shown below panel B. (C) In vitro proliferation response measured in the presence of PG antigen. Values represent Delta counts per minute (c.p.m.) (PG-stimulated c.p.m. - ctrl c.p.m.) (mean +/- SEM) of spleen cells (n = 3 animals were sacrificed at each time point). (D) Serum IgG1 (black symbols) and IgG2a (white symbols) concentrations against mouse PG (n = 3 animals at each time point).
###end p 48
###begin p 49
###xml 154 161 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 245 253 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 372 379 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 398 406 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 573 580 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
After the first PG injection, on days 5, 10 and 20, there were measurable amounts of spontaneous IL-12/23 p40, IL-17 and IFNgamma in BALB/c PLF cultures (Fig. 2A); the level of IFNgamma was elevated after the second PG injection. In response to in vitro PG stimulation, PLF cells secreted large amounts of IFNgamma, IL-17 and IL-6 and lesser amounts of TNFalpha and IL-4 (Fig. 2A). In general, the in vitro cytokine-producing capacity of PLF cells decreased after the third PG injection, with TNFalpha and IL-4 in PG-stimulated PLF cell cultures being the only exceptions (Fig. 2A).
###end p 49
###begin p 50
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
Since we noticed earlier that DDA alone also triggered T cell influx into the peritoneal cavity, we measured the spontaneous in vitro cytokine-producing capacity of PLF cells isolated from BALB/c mice injected once with PBS/DDA. We detected IL-12/23 p40, IL-17, IFNgamma and TNFalpha, although in lesser amounts than in the supernatants of PLF cells of mice immunized with PG in DDA (data not shown).
###end p 50
###begin p 51
###xml 102 110 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 226 233 222 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
In conclusion, BALB/c PLF cells can produce considerable amounts of IFNgamma, IL-17 and IL-12/23 p40, in vitro spontaneously, and the levels of these cytokines further increase upon antigen challenge, except for the IL-12/23 (Fig. 2A). A similar spontaneous cytokine secretion pattern, with the exception of IL-4 and IL-6, was found when cells were harvested from PBS/DDA-injected mice (data not shown).
###end p 51
###begin title 52
Cytokines measured in BALB/c spleen cultures
###end title 52
###begin p 53
###xml 191 192 191 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 399 408 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2B&#8211;C</xref>
###xml 425 449 425 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
After i.p. injection, antigen is first processed by local cells; however, the systemic response is controlled by the spleen. Since the direction of the immune response, as determined by the Th1/Th2 balance, is mainly regulated by pro- and anti-inflammatory cytokines in different lymphatic compartments (27), we compared cytokine production in non-stimulated and PG-stimulated spleen cell cultures (Fig. 2B-C; , available at International Immunology Online).
###end p 53
###begin p 54
###xml 142 149 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2B</xref>
###xml 166 190 162 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 409 416 397 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2B</xref>
###xml 433 457 421 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
Spleen cells spontaneously secreted relatively large amounts of IL-6, IL-12/23 p40, IL-17 and IFNgamma during the entire immunization period (Fig. 2B; , available at International Immunology Online). Increased production of IL-17 and IFNgamma was detected as early as 10 days after the first PG injection, and IL-17 and IFNgamma levels reached a maximum in spleen cell cultures after the second PG injection (Fig. 2B; , available at International Immunology Online). Spleen cells from mice that received only DDA secreted measurable amounts of IL-12/23 p40, IL-17, IFNgamma and TNFalpha 5 and 10 days after a single DDA injection (data not shown).
###end p 54
###begin title 55
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Splenic T cell response to PG and serum antibody levels in BALB/c mice
###end title 55
###begin p 56
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 79 86 79 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2C</xref>
###xml 217 224 217 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2C</xref>
###xml 317 324 317 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2C</xref>
###xml 410 414 410 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
Next, we monitored the in vitro proliferation responses of spleen cells to PG (Fig. 2C). BALB/c splenocytes showed significant proliferation upon PG stimulation as early as 5 and 10 days after the first PG injection (Fig. 2C), and spleen cell proliferation further increased after the second and third PG injections (Fig. 2C). The results of the proliferation assays correlated with the ratio of activated CD25high CD4+ T cells in the spleen as assessed by flow cytometry at the same time points (data not shown).
###end p 56
###begin p 57
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 370 377 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2D</xref>
###xml 496 503 496 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2D</xref>
###xml 286 291 <span type="species:ncbi:10090">mouse</span>
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
###xml 566 571 <span type="species:ncbi:9606">human</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
It has been previously shown that in the development of PGIA, in addition to T cells, antibodies produced by B cells in response to PG immunization also play an indispensable role (2, 18). Since cartilage destruction in PGIA is most likely amplified by auto-antibody production against mouse cartilage PG, we assessed circulating mouse PG-specific auto-antibody levels (Fig. 2D). BALB/c mice produced significant amounts of IgG1 and IgG2a to mouse PG after the second and third PG immunizations (Fig. 2D). As expected, increasing concentrations of IgG1 and IgG2a to human PG were also detectable in the serum of mice after the second immunization (data not shown).
###end p 57
###begin title 58
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Comparison of PG-specific immune responses in BALB/c and DBA/2 mice
###end title 58
###begin p 59
###xml 81 88 81 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1A</xref>
###xml 272 280 272 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Tables 1</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">2</xref>
###xml 505 511 505 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 891 892 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
The significant difference in the T cell numbers in PLF between the two strains (Fig. 1A) already indicated that there could be substantial differences between their immune responses to PG. Beyond exploring the differences in cellular composition between the two strains (Tables 1 and 2), we monitored cytokine and antibody production following repeated PG immunization that may have contributed to the activation of T and B cells and their differentiation into an arthritogenic phenotype in BALB/c mice (Fig. 2). To decipher which components of these 'BALB/c-specific' features play crucial roles in PGIA susceptibility, we made a systematic comparison with arthritis-resistant DBA/2 mice using approximately the same number of animals and exactly the same immunization protocol. Although the DBA/2 strain carries the same MHC (H-2d) as the BALB/c strain, DBA/2 mice are resistant to PGIA (2, 18, 24).
###end p 59
###begin p 60
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 81 88 81 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3A</xref>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 346 353 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3A</xref>
###xml 492 499 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figs 3B</xref>
###xml 504 506 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2B</xref>
###xml 523 547 515 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
The in vitro cytokine production profile of PLF cells harvested from DBA/2 mice (Fig. 3A) was fundamentally different from that of BALB/c (Fig. 2A). IL-6 was the most dominant cytokine at all time points of the immunization protocol in DBA/2 PLF cell cultures, whereas minimal or no IL-4, IL-12/23 p40, IL-17 or IFNgamma production was detected (Fig. 3A). DBA/2 spleen cells produced significantly less IL-17 and IFNgamma at almost all time points after immunization than BALB/c splenocytes (Figs 3B and 2B; , available at International Immunology Online).
###end p 60
###begin p 61
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 190 192 190 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 265 273 265 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 443 444 437 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 568 569 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 627 628 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 658 667 652 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2(D)</xref>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 558 563 <span type="species:ncbi:10090">mouse</span>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
Kinetics of the immune response to PG in DBA/2 mice. In vitro cytokine production of PLF (A) and spleen (B) cells. Numbers show the mean cytokine concentrations of experimental groups (pg 10-6 cells). Grayscale intensity coding is shown below the spleen panel. (C) In vitro T cell proliferation in response to PG stimulation. Bars represent Delta counts per minute (c.p.m.) (PG-stimulated c.p.m. - ctrl c.p.m.) (mean +/- SEM) of spleen cells (n = 3 animals at each time point). (D) Serum IgG1 (black symbols) and IgG2a (white symbols) concentrations against mouse PG (n = 3 animals at each time point) in DBA/2 mice. Note, the y-axis scale is the same as in Fig. 2(D).
###end p 61
###begin p 62
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 172 179 172 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3C</xref>
###xml 271 278 271 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3C</xref>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3D</xref>
###xml 475 482 475 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2D</xref>
###xml 314 319 <span type="species:ncbi:10090">mouse</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
DBA/2 spleen cultures exhibited higher in vitro proliferation responses to PG when compared with identical BALB/c cell cultures between the second and third immunizations (Fig. 3C). However, after the third immunization, this spleen cell proliferation capacity declined (Fig. 3C). The auto-antibody levels against mouse PG in the sera of DBA/2 mice were only 10-30% of those measured in BALB/c mice when compared at the same time points of immunization (compare Fig. 3D with Fig. 2D).
###end p 62
###begin title 63
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Transfer of PGIA to SCID mice with PLF cells from BALB/c mice
###end title 63
###begin p 64
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 505 511 505 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 382 386 <span type="species:ncbi:10090">mice</span>
PGIA can be adoptively transferred into syngeneic SCID mice using spleen cells from arthritic BALB/c donors and PG antigen (20). Side-by-side comparison of BALB/c and DBA/2 immune responses to PG revealed the most pronounced difference in T cells and their cytokine production in the peritoneal cavity. Since the arthritogenic potential of peritoneal cells from PG-immunized BALB/c mice has never been tested, we injected PLF cells, comprised mostly of T cells and conventional B cells and some B1 cells (Fig. 1).
###end p 64
###begin p 65
###xml 58 65 58 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 519 526 519 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 559 563 <span type="species:ncbi:10090">mice</span>
The results of the transfer experiments are summarized in Table 3. PGIA was transferred most efficiently (100% incidence, highest arthritis score) with PLF cells from arthritic BALB/c mice (Table 3, Group C). Importantly, transfer of PGIA was also possible with PLF cells harvested 10 days after the second i.p. injection from not yet arthritic BALB/c mice (Table 3, Group B). There was no arthritis at all in the SCID recipients when PLF cells harvested from mice immunized only once with PG and DDA were transferred (Table 3, Group A). PLF cells from DBA/2 mice induced mild arthritis (using the same conditions) only after repeated (four times) PG/DDA injections (data not shown).
###end p 65
###begin p 66
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Summary of the results of peritoneal cell transfer to SCID mice
###end p 66
###begin p 67
###xml 236 244 236 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 540 541 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 647 652 <span type="species:ncbi:9606">human</span>
###xml 662 667 <span type="species:ncbi:10090">mouse</span>
PLF cells from BALB/c donors after one, two or three PG immunizations were injected with PG into SCID recipients. Transfers were repeated after 14 days. Table shows the incidence, onset and arthritis score of transferred SCID mice, the in vitro measured immunologic parameters (PG-specific T cell proliferation and cytokine production) and serum antibody levels in recipients at the end of transfer experiments (45 days after the second transfer). All values are shown as mean +/- SEM. Numbers in bold face (Group C) indicate significant (*P < 0.05) differences when compared with either Group A or B. NA, not applicable; ND, not detected; hu PG, human PG; mPG, mouse PG.
###end p 67
###begin p 68
Days after the second transfer.
###end p 68
###begin p 69
SI, stimulation index.
###end p 69
###begin p 70
###xml 296 300 296 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 343 356 343 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4A and B</xref>
###xml 373 397 373 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 516 529 516 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4C and D</xref>
###xml 546 570 546 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 5 9 <span type="species:ncbi:10090">mice</span>
SCID mice were sacrificed 45 days after the second cell transfer, and cells from PLF and spleen were harvested. Flow cytometric analysis revealed that these compartments in all SCID recipients were efficiently repopulated with donor BALB/c PLF lymphocytes, mainly T cells (most of which were CD44high CD4+), conventional B cells and B1 cells (Fig. 4A and B; , available at International Immunology Online). Moreover, large proportions of both T and B cells expressed CD69 and CD25 activation markers at high levels (Fig. 4C and D; , available at International Immunology Online).
###end p 70
###begin p 71
###xml 131 138 131 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 471 479 471 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 597 604 597 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 712 736 712 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
###xml 524 529 <span type="species:ncbi:9606">human</span>
###xml 534 539 <span type="species:ncbi:10090">mouse</span>
Flow cytometric evaluation of cellular reconstitution in SCID recipients after transfer of PLF cells from arthritic BALB/c donors (Table 3, Group C). (A and B) Representative flow cytometric contour plots show the cellular composition of PLF and spleen of SCID recipients. (C and D) Activation marker (CD69 and CD25) expression of T and B cells is shown on histograms (T cells: green and B cells: magenta). Corresponding data (PG-induced T cell proliferation, PG-induced in vitro cytokine production and serum antibodies to human and mouse PG) of SCID recipients from all groups are summarized in Table 3, and more detailed information for cellular composition of PLF and spleen are summarized in  (available at International Immunology Online).
###end p 71
###begin p 72
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 75 82 75 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 309 316 305 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 437 444 433 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 338 343 <span type="species:ncbi:9606">human</span>
###xml 348 353 <span type="species:ncbi:10090">mouse</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
PG-induced in vitro T cell proliferation was highest in Group C SCID mice (Table 3). In vitro production of IL-4 and IL-6 by spleen cells upon PG stimulation was significantly higher in Group C than in Group A or B (Table 3). IFNgamma and IL-17 productions were only detectable in spleen cultures of Group C (Table 3). Serum IgG1 to both human and mouse PG was highest in Group C, while IgG2a to human PG was only detectable in Group C (Table 3).
###end p 72
###begin p 73
###xml 309 310 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 193 197 <span type="species:ncbi:10090">mice</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
In summary, we found that BALB/c PLF cells co-injected with antigen were able to transfer PGIA to SCID hosts even if the cells were harvested from twice-immunized, but not yet arthritic, donor mice. Importantly, these PLF cells were already committed to be highly arthritogenic, since the transfer of 1-3 x 106 cells was sufficient to induce arthritis, whereas conventional transfer usually required 1-2 x 107 spleen cells from severely arthritic BALB/c mice (20).
###end p 73
###begin title 74
Discussion
###end title 74
###begin p 75
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
In this study, we have analyzed and compared the distribution of T and B lymphocytes and their responses to PG immunization in PLF and spleen of arthritis-susceptible BALB/c and arthritis-resistant DBA/2 mice. The early changes induced by PG immunization in these tissue compartments, especially in the peritoneal cavity, most likely led to the differentiation and activation of arthritogenic T and B cells which then triggered synovial joint inflammation in BALB/c mice. The adjuvant (DDA) proved to be a major contributor to these early cellular changes, but DDA alone was insufficient to induce any inflammatory reaction in synovial joints as confirmed by histology.
###end p 75
###begin p 76
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
Relatively, early after the first i.p. immunization, there was a robust T cell influx and/or proliferation in the peritoneal cavity in BALB/c mice, accompanied by the disappearance of the resident naive B1 cell population. Upon repeated immunizations, this skew in the cellular composition became more apparent. The continuously elevated T cell numbers were most likely the result of both the homing of antigen-specific T cells to the peritoneum and the local expansion of resident T cells. This notion is further supported by the fact that the absence of neither CD44 nor CD62L molecules [in knockout (KO) mice] could completely abolish the T cell number increase in the peritoneal cavity (data not shown). The transient decrease in T cell number after the second PG/DDA injection might be the result of the systemic (joint) recirculation of autoreactive T cells and activation-induced cell death locally in the peritoneal cavity (28). The T cell-enriched peritoneal effusion in BALB/c mice, which could not be detected in arthritis-resistant DBA/2 mice, might well be one of the critical upstream contributors that set the stage for the development of PGIA.
###end p 76
###begin p 77
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
In BALB/c mice, a dominant production of pro-inflammatory cytokines (IL-6, IL-12/23 p40, IFNgamma, IL-17 and TNFalpha) was already detected at the early stages of i.p. immunization-induced peritonitis at 5 and 10 days following the first i.p. injection. This was not due to the injection itself, because i.p. injection of 200 mul PBS did not induce cytokine production and had no evident effect upon peritoneal cell composition (our unpublished data). The massive shift in cellular composition and cytokine production in PLF, which might be due to the combined effects of adjuvant and strain specific factors, may dictate arthritis susceptibility in BALB/c and resistance in DBA/2 mice.
###end p 77
###begin p 78
###xml 44 45 44 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 191 192 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 204 206 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 208 210 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 219 220 216 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 227 228 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 304 306 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 308 310 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 314 315 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 367 369 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 371 373 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 494 496 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 574 576 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 578 580 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 611 613 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 656 658 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 704 706 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 766 768 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 790 797 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 881 883 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 885 887 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 290 295 <span type="species:ncbi:10090">mouse</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 564 569 <span type="species:ncbi:9606">human</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
###xml 1470 1474 <span type="species:ncbi:10090">mice</span>
###xml 1795 1799 <span type="species:ncbi:10090">mice</span>
###xml 1869 1873 <span type="species:ncbi:10090">mice</span>
IL-12 and IL-27 have been shown to promote Th1 differentiation, whereas IL-6, transforming growth factor beta and IL-23 (which shares a common p40 chain with IL-12) promote and maintain the Th17 lineage (29, 30). Both Th1 and Th17 cytokines have been associated with arthritis in different mouse models (21, 31). Th1 dominance was shown to be characteristic of PGIA (21, 22), whereas the absence of IL-17 alone in IL-17a-deficient BALB/c mice did not seem to have a significant effect on PGIA (32). Nonetheless, IL-17 has been shown to be an important mediator in human RA (33, 34), collagen-induced arthritis (35) and spontaneous arthritis in either SKG (36) or IL-1 receptor antagonist-deficient mice (37), as well as in experimental autoimmune encephalomyelitis (38). In contrast to the in vivo experiments in which IL-17a deficiency alone seems to play a limited role in PGIA (32, 39), we show that one of the prominent cytokines produced during the PG immunization period is IL-17 in BALB/c mice. This suggests that in addition to IFNgamma, IL-17 might play a role in PGIA similar to its implicated role in other autoimmune disease models and RA. Indeed, IFNgamma and IL-17 were the cytokines that were produced in significantly lesser amounts at most time points (especially by the PLF cells) in the resistant DBA/2 strain, suggesting that high levels of IFNgamma and IL-17 might contribute to PGIA susceptibility. Results obtained in IFNgamma and IL-17 double KO mice (A. Finnegan, personal communication) revealed the role of IL-17 in PGIA. While IFNgamma is a key cytokine in PGIA, IFNgamma deficiency alone does not abolish completely PGIA. This 'residual arthritis', however, is completely eliminated by additional IL-17 deficiency. Thus, the absence of IL-17 in the IL-17a-deficient mice most likely is compensated by IFNgamma. In turn, in wild-type BALB/c mice, both cytokines are present and involved in PGIA.
###end p 78
###begin p 79
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 449 457 449 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 475 476 475 476 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 651 657 651 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 662 669 662 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 771 772 771 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 775 776 775 776 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 965 966 965 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 973 974 973 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 1344 1350 1344 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1352 1354 1352 1354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1117 1121 <span type="species:ncbi:10090">mice</span>
###xml 1259 1263 <span type="species:ncbi:10090">mice</span>
###xml 1464 1469 <span type="species:ncbi:10090">mouse</span>
B cells are excellent APCs (40), and B cells from PG-immunized BALB/c mice are 1000 times more effective APCs than peritoneal macrophages (4, 41). Antigen presentation is known to influence both the magnitude and the direction of the immune response (42). It has been shown recently that B1 and conventional B (B2) cells induce different pathways of T cell differentiation (11). According to Zhong et al. (11), when B1 cells were used as APCs under in vitro conditions, Th1/Th17 cells accumulated, whereas conventional B cells as APCs induced the proliferation of Tregs. In naive (non-immunized) conditions, the peritoneal cavity is rich in B1 cells (Fig. 1 and Table 1), and these B1 cells, through antigen presentation, may initially direct the immune response toward Th1/Th17 differentiation. Although the number of B1 cells decreases upon repeated PG/DDA injections, a low number of B1 cells may be sufficient for maintaining the polarization and dominance of Th1 and Th17 CD4+ cells in the peritoneal cavity of BALB/c mice. In contrast, conventional B2 cells represent the majority of B cells in spleen of DBA/2 mice. This may be one of the reasons for the expansion of the splenic Treg population detected at day 5 after the first PG injection in DBA/2 mice (data not shown). Similar expansion of splenic Tregs was also observed by Zhong et al. (11). This early Treg induction in the spleen could also contribute to the PGIA-resistant phenotype of the DBA/2 mouse strain.
###end p 79
###begin p 80
###xml 189 195 189 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 400 401 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 408 409 404 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 457 458 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 460 462 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 464 466 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 927 931 <span type="species:ncbi:10090">mice</span>
###xml 1322 1326 <span type="species:ncbi:10090">mice</span>
Upon the second PG injection, T and B cells are reactivated in the peritoneal cavity, and this event is accompanied by a robust change in the T and B cell composition and activation state (Fig. 1). This change is reflected by the production of IFNgamma, IL-17 and auto-antibodies against mouse PG in BALB/c, but not in DBA/2 mice. These PG-specific auto-antibodies, together with activated effector Th1 and Th17 cells, may find their targets in the joints (5, 41, 43). Deposition of PG-specific antibodies in the joints and T cell migration to the synovium, also indicated by the transient decrease in the T cell number of the PLF 10 days after the second PG + DDA injection, may trigger the effector phase of autoimmune arthritis, amplifying the local response through pro-inflammatory cytokine (IL-1beta, TNFalpha, IFNgamma, IL-17 and IL-6) production, thereby leading to progressive joint tissue destruction. Since in DBA/2 mice there was significantly less influx of T cells into the peritoneal cavity, T cell help was probably not sufficient for auto-antibody production. Subtle differences in co-stimulation, which might influence the T-B cell interactions, cannot be ruled out between the two strains. Our PLF cell transfer experiments show that boosting peritoneal cells with a second PG injection in donor BALB/c mice enhanced the arthritogenic potential of these cells in SCID recipients. This supports the hypothesis that, although PG-primed T and B cells already appear in the peritoneum after the first immunization, their reactivation via clonal expansion is necessary to reach the fully 'armed effector' state.
###end p 80
###begin p 81
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 557 563 <span type="species:ncbi:9606">humans</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
A potentially interesting implication of this study is the importance of the peritoneal lymphoid cells in controlling autoimmune joint inflammation. B1 cells, residing in the peritoneal cavity, have been implicated in autoimmunity (44). They produce auto-antibodies spontaneously at low concentrations, and these cells may be considered as physiological regulators of autoimmunity (45). Although there is no direct evidence for their role in RA so far, it might be interesting to speculate that changes in the physiological peritoneal milieu in susceptible humans, similar to what happens in BALB/c mice as a consequence of i.p. PG/DDA injections, could pave the way to autoimmune joint inflammation. Theoretically, repeated peritoneal antigen (endogenous or exogenous) stimuli, together with chronic exposure to chemicals with potential adjuvant activity, might contribute to such cellular changes, eventually leading to impaired immune regulation.
###end p 81
###begin p 82
###xml 339 340 339 340 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 628 634 628 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 1481 1483 1473 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1428 1432 <span type="species:ncbi:10090">mice</span>
A key observation of this study is that injection of adjuvant (DDA) alone induced very similar changes in peritoneal cell composition as the injection of DDA with PG. However, only BALB/c mice injected with PG/DDA developed strong antigen-specific immune responses and arthritis. DDA has been shown to skew the immune response toward the Th1 direction (46, 47) in addition to strongly activating innate immune cells (14). Here, we show that DDA induces the recruitment of T cells into the peritoneum, which is in line with earlier observations (17), but the kinetics of T cell influx was different when the antigen was present (Fig. 1). This effect, however, can be attributable to the local induction of inflammatory adhesion molecules and chemokines. The propensity of these T cells to produce IFNgamma, TNFalpha, IL-12 and IL-17 in the early stage of immunization may create an optimal milieu for the differentiation and activation of autoimmune T and B cells when antigen (PG) is present. Such peritoneal T cell response was lacking in DBA/2 mice, which raises the possibility that the adjuvant itself might not effectively activate innate immune cells in this strain. On the contrary, systemic T cell response and serum antibody levels against the immunizing antigen showed that the immunization was effective, although at different levels, in both strains. This correlates with earlier studies which have shown that DBA/2 mice, similar to BALB/c, are good responders to DDA (48).
###end p 82
###begin p 83
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
As we have shown, PGIA resistance in DBA/2 mice is not the consequence of the lack of the systemic immune response against the immunizing (human) PG. However, the 'autoimmune switch' and the subsequent immune attack on the joints (self-PG) can only be observed in BALB/c mice. Our preliminary transfer experiments with PLF cells from hyper-immunized DBA/2 mice also support the idea that indeed, DBA/2 cells carry some arthritogenic potential, which, otherwise, is suppressed in the original wild-type background. Several candidate molecules can be involved in the development of autoimmunity, including innate immune receptors, like Toll-like receptors (TLRs) (49, 50), and co-stimulatory molecules (51). For example, flow cytometry analysis has shown that higher percentage of peritoneal macrophages express TLR1 in DBA/2 than in BALB/c mice (data not shown).
###end p 83
###begin p 84
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
Therefore, we conclude that the arthritis-susceptible phenotype of BALB/c mice is due to an autoimmune switch during the immunization with human PG. This is potentially determined by differences in the adjuvant response, locally, in the peritoneal cavity and in joint-draining lymph nodes of BALB/c mice with PGIA (4). The profound immunophenotypic differences between the two strains found here, in addition to data from genetic studies (2, 52), may advance our understanding of the critical events leading to autoimmunity in PGIA in the BALB/c strain.
###end p 84
###begin title 85
Supplementary data
###end title 85
###begin p 86
###xml 18 42 18 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Immunology</italic>
 are available at International Immunology Online.
###end p 86
###begin title 87
Funding
###end title 87
###begin p 88
###xml 0 29 0 29 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 29 76 29 76 <!-- oupReleaseDelayRemoved from OA Article (12|0) -->
###xml 77 235 77 235 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) and J. O. Galante M.D., D.Sc. endowment chair; Grainger Foundation (Chicago)</grant-sponsor>
National Institutes of Health oupReleaseDelayRemoved from OA Article (12|0) /National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) and J. O. Galante M.D., D.Sc. endowment chair; Grainger Foundation (Chicago).
###end p 88
###begin title 89
Supplementary Material
###end title 89
###begin title 90
[Supplementary Data]
###end title 90
###begin title 91
Abbreviations
###end title 91
###begin p 92
antigen-presenting cell
###end p 92
###begin p 93
dimethyldioctadecyl-ammonium bromide
###end p 93
###begin p 94
intra-peritoneal
###end p 94
###begin p 95
knockout
###end p 95
###begin p 96
proteoglycan
###end p 96
###begin p 97
PG aggrecan-induced arthritis
###end p 97
###begin p 98
peritoneal lavage fluid
###end p 98
###begin p 99
rheumatoid arthritis
###end p 99
###begin p 100
standard error of the mean
###end p 100
###begin p 101
tumor necrosis factor
###end p 101
###begin p 102
Toll-like receptor
###end p 102
###begin p 103
regulatory T cell
###end p 103
###begin p 104
###xml 160 165 <span type="species:ncbi:9606">human</span>
###xml 265 270 <span type="species:ncbi:9606">human</span>
###xml 454 458 <span type="species:ncbi:10090">mice</span>
The authors thank their colleagues and members of Midwest Orthopedics (Rush University Medical Center, Chicago), especially Joshua J. Jacobs, for the supply of human cartilage material. We appreciate the help of Gabor Hutas and Balint Farkas with the collection of human cartilage samples and thank the members of the Comparative Research Center (Rush University Medical Center, Chicago) and Jeffrey Oswald for their assistance in studies involving SCID mice.
###end p 104
###begin article-title 105
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology
###end article-title 105
###begin article-title 106
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms and genetics
###end article-title 106
###begin article-title 107
T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis
###end article-title 107
###begin article-title 108
Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation
###end article-title 108
###begin article-title 109
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (nonimmunized) BALB/c mice
###end article-title 109
###begin article-title 110
Defense mechanisms of the peritoneal cavity
###end article-title 110
###begin article-title 111
###xml 43 48 <span type="species:ncbi:9606">human</span>
Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study
###end article-title 111
###begin article-title 112
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Generation, expansion, migration and activation of mouse B1 cells
###end article-title 112
###begin article-title 113
Role of natural and immune IgM antibodies in immune responses
###end article-title 113
###begin article-title 114
###xml 95 133 95 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paracoccidioides brasiliensis in vitro</italic>
###xml 95 124 <span type="species:ncbi:121759">Paracoccidioides brasiliensis</span>
Characterization of B-1b cells as antigen presenting cells in the immune response to gp43 from Paracoccidioides brasiliensis in vitro
###end article-title 114
###begin article-title 115
Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells
###end article-title 115
###begin article-title 116
Differential development of progenitor activity for three B-cell lineages
###end article-title 116
###begin article-title 117
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
###end article-title 117
###begin article-title 118
Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype
###end article-title 118
###begin article-title 119
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: the role of endogenous interleukin 1 in proliferative responses
###end article-title 119
###begin article-title 120
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
###end article-title 120
###begin article-title 121
The enhancement of humoral and cellular immune responses by dimethyldioctadecylammonium bromide
###end article-title 121
###begin article-title 122
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan
###end article-title 122
###begin article-title 123
###xml 105 111 <span type="species:ncbi:10090">murine</span>
Identification of multiple loci linked to inflammation and autoantibody production by a genome scan of a murine model of rheumatoid arthritis
###end article-title 123
###begin article-title 124
###xml 66 70 <span type="species:ncbi:10090">mice</span>
T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system
###end article-title 124
###begin article-title 125
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines
###end article-title 125
###begin article-title 126
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis
###end article-title 126
###begin article-title 127
Interleukin-4 regulates proteoglycan-induced arthritis by specifically suppressing the innate immune response
###end article-title 127
###begin article-title 128
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Proteoglycan aggrecan-induced arthritis. A murine autoimmune model of rheumatoid arthritis
###end article-title 128
###begin article-title 129
CD43 (S7) expression identifies peripheral B cell subsets
###end article-title 129
###begin article-title 130
###xml 86 101 <span type="species:ncbi:10090">transgenic mice</span>
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice
###end article-title 130
###begin article-title 131
###xml 142 146 <span type="species:ncbi:10090">mice</span>
IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice
###end article-title 131
###begin article-title 132
IL-4 potentiates activated T cell apoptosis via an IL-2-dependent mechanism
###end article-title 132
###begin article-title 133
All in the family: IL-27 suppression of T(H)-17 cells
###end article-title 133
###begin article-title 134
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
###end article-title 134
###begin article-title 135
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice
###end article-title 135
###begin article-title 136
Development of proteoglycan-induced arthritis is independent of IL-17
###end article-title 136
###begin article-title 137
###xml 30 38 <span type="species:ncbi:9606">patients</span>
IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
###end article-title 137
###begin article-title 138
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 45 53 <span type="species:ncbi:9606">patients</span>
High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism
###end article-title 138
###begin article-title 139
IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis
###end article-title 139
###begin article-title 140
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice
###end article-title 140
###begin article-title 141
###xml 112 116 <span type="species:ncbi:10090">mice</span>
IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist
###end article-title 141
###begin article-title 142
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
###end article-title 142
###begin article-title 143
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption
###end article-title 143
###begin article-title 144
Antigen presentation by B cells and its significance in T-B interactions
###end article-title 144
###begin article-title 145
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis
###end article-title 145
###begin article-title 146
Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages
###end article-title 146
###begin article-title 147
###xml 30 36 <span type="species:ncbi:10090">murine</span>
Trafficking of CD44-deficient murine lymphocytes under normal and inflammatory conditions
###end article-title 147
###begin article-title 148
The paradox of CD5-expressing B cells in systemic lupus erythematosus
###end article-title 148
###begin article-title 149
B lymphocytes on the front line of autoimmunity
###end article-title 149
###begin article-title 150
###xml 224 228 <span type="species:ncbi:10090">mice</span>
Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice
###end article-title 150
###begin article-title 151
###xml 84 111 <span type="species:ncbi:12814">respiratory syncytial virus</span>
DDA adjuvant induces a mixed Th1/Th2 immune response when associated with BBG2Na, a respiratory syncytial virus potential vaccine
###end article-title 151
###begin article-title 152
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Variable expression of delayed hypersensitivity in different mouse strains using dimethyl dioctadecyl ammonium bromide as an adjuvant
###end article-title 152
###begin article-title 153
Toll-like receptors in autoimmunity
###end article-title 153
###begin article-title 154
Toll-like receptors: paving the path to T cell-driven autoimmunity?
###end article-title 154
###begin article-title 155
The balance of immune responses: costimulation verse coinhibition
###end article-title 155
###begin article-title 156
Antigen-induced differential gene expression in lymphocytes and gene expression profile in synovium prior to the onset of arthritis
###end article-title 156

